| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| adsorberet tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
1 |
| adsorberet difteri- og tetanustoxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
2 |
| difteri- og tetanustoxoider og helcellekighostevaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
3 |
| adsorberet tetanusvaccine injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
1 |
| adsorberet tetanusvaccine injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
1 |
| adsorberet tetanustoxoid 20 enheder/ml 0,5 ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
|
| Vaccine product containing only whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
3 |
| Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
2 |
| Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid adsorbed |
Inferred relationship |
Some |
1 |
FHIR